|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Massachusetts General Hospital |
|---|---|
| Collaborator: |
American Society for Gastrointestinal Endoscopy |
| Information provided by: | Massachusetts General Hospital |
| ClinicalTrials.gov Identifier: | NCT00671463 |
Purpose
The purpose of this study is to investigate an intervention to prevent complications after pancreas surgery. The goal is to determine if placing a stent into the pancreatic duct before surgery will decrease or prevent leaking from the pancreatic duct after surgery. Leaks are common after pancreas surgery and can result in serious problems and post-operative pain. The study will compare two groups. One group will have the stent before surgery, and the other group will have standard pancreas surgery, no endoscopy, and no stent.
| Condition | Intervention |
|---|---|
|
Pancreatic Surgery Pancreatic Duct Stenting Pancreatic Cancer Distal Pancreatectomy Pancreatic Diseases Pancreatic Cyst Pancreatic Ducts |
Procedure: Pancreatic duct stenting |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Prevention |
| Official Title: | Leak Elimination After Pancreatic Stenting, a Randomized Controlled Trial |
| Estimated Enrollment: | 80 |
| Study Start Date: | April 2008 |
| Estimated Primary Completion Date: | April 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Pre-operative pancreatic duct stenting
|
Procedure: Pancreatic duct stenting
In the treatment arm, patients will have a pancreatic duct stent placed prior to having their distal pancreatectomy.
|
|
No Intervention: 2
Control group, no endoscopy and no stent pre-operatively
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, Massachusetts | |
| Massachusetts General Hospital | |
| Boston, Massachusetts, United States, 02114 | |
| Study Director: | Field F Willingham, MD, MPH | MGH |
| Study Director: | Denise W Gee, MD | MGH |
| Study Director: | Sevdenur Cizginer, MD | MGH |
| Principal Investigator: | David W Rattner, MD | MGH |
| Principal Investigator: | William R Brugge, MD | MGH |
More Information
| Responsible Party: | William Brugge, MD / Director of Endoscopy, Massachusetts General Hospital |
| ClinicalTrials.gov Identifier: | NCT00671463 History of Changes |
| Other Study ID Numbers: | 2007P000965 |
| Study First Received: | May 1, 2008 |
| Last Updated: | May 2, 2008 |
| Health Authority: | United States: Institutional Review Board |
|
Pancreas surgery Pancreatic adenocarcinoma Pancreatic neuroendocrine tumor Pancreatic duct stenting |
|
Pancreatic Cyst Pancreatic Diseases Pancreatic Neoplasms Cysts Neoplasms |
Digestive System Diseases Digestive System Neoplasms Neoplasms by Site Endocrine Gland Neoplasms Endocrine System Diseases |